Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather Neuhalfen

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Acta Haematologica|October 1, 2023
Fostamatinib or Thrombopoietin for the Treatment of Chronic Immune Thrombocytopenia in Adult Patients: A Real-World Assessment of Safety, Effectiveness and CostGeorge Dranitsaris, Aaron Peevyhouse, Tiffany Wood, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 27, 2023
Diagnosis and management of systemic mastocytosis in a community hematology settingGeorge Dranitsaris, Heather Neuhalfen, Aaron Peevyhouse, et al.
JCO Oncology Practice|April 22, 2026
Evaluating Effective Biomarker Testing for Advanced Non-Small Cell Lung Cancer in US Community Oncology PracticesChristian A Thomas, Sibel Blau, Heather Neuhalfen, et al.
American Journal of Clinical Oncology|December 10, 2025
Disparities in Biopsy Practice in Metastatic Breast Cancer Patients Managed in Community Oncology Practices in the United States: Implications for Guideline-Concordant CareGeorge Dranitsaris, Heather Neuhalfen, Nik Seifter, et al.
Leukemia & Lymphoma|June 24, 2026
Hypertension and time to treatment failure with acalabrutinib and ibrutinib in treatment-naïve CLL/SLLMayur S Narkhede, Sibel Blau, Aaron Peevyhouse, et al.
Journal of Medical Economics|December 27, 2025
A real-world study evaluating drug tolerability and health care resource use with acalabrutinib vs ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphomaGeorge Dranitsaris, Aaron Peevyhouse, Heather Neuhalfen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Acta Haematologica|October 1, 2023
Fostamatinib or Thrombopoietin for the Treatment of Chronic Immune Thrombocytopenia in Adult Patients: A Real-World Assessment of Safety, Effectiveness and CostGeorge Dranitsaris, Aaron Peevyhouse, Tiffany Wood, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 27, 2023
Diagnosis and management of systemic mastocytosis in a community hematology settingGeorge Dranitsaris, Heather Neuhalfen, Aaron Peevyhouse, et al.
JCO Oncology Practice|April 22, 2026
Evaluating Effective Biomarker Testing for Advanced Non-Small Cell Lung Cancer in US Community Oncology PracticesChristian A Thomas, Sibel Blau, Heather Neuhalfen, et al.
American Journal of Clinical Oncology|December 10, 2025
Disparities in Biopsy Practice in Metastatic Breast Cancer Patients Managed in Community Oncology Practices in the United States: Implications for Guideline-Concordant CareGeorge Dranitsaris, Heather Neuhalfen, Nik Seifter, et al.
Leukemia & Lymphoma|June 24, 2026
Hypertension and time to treatment failure with acalabrutinib and ibrutinib in treatment-naïve CLL/SLLMayur S Narkhede, Sibel Blau, Aaron Peevyhouse, et al.
Journal of Medical Economics|December 27, 2025
A real-world study evaluating drug tolerability and health care resource use with acalabrutinib vs ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphomaGeorge Dranitsaris, Aaron Peevyhouse, Heather Neuhalfen, et al.
Pageof 1